BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 16709729)

  • 1. Protease analysis by neoepitope approach reveals the activation of MMP-9 is achieved proteolytically in a test tissue cartilage model involved in bone formation.
    Lee ER; Lamplugh L; Kluczyk B; Mort JS; Leblond CP
    J Histochem Cytochem; 2006 Sep; 54(9):965-80. PubMed ID: 16709729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
    Geurts N; Martens E; Van Aelst I; Proost P; Opdenakker G; Van den Steen PE
    Biochemistry; 2008 Feb; 47(8):2689-99. PubMed ID: 18237197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active gelatinase B is identified by histozymography in the cartilage resorption sites of developing long bones.
    Lee ER; Murphy G; El-Alfy M; Davoli MA; Lamplugh L; Docherty AJ; Leblond CP
    Dev Dyn; 1999 Jul; 215(3):190-205. PubMed ID: 10398530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoepitopes reveal the features of type II collagen cleavage and the identity of a collagenase involved in the transformation of the epiphyses anlagen in development.
    Lee ER; Lamplugh L; Kluczyk B; Leblond CP; Mort JS
    Dev Dyn; 2009 Jun; 238(6):1547-63. PubMed ID: 19441084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide.
    Galazka G; Windsor LJ; Birkedal-Hansen H; Engler JA
    Biochemistry; 1996 Aug; 35(34):11221-7. PubMed ID: 8780527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM; Rowan AD; Cawston TE; Young DA
    Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of nitroglycerin-induced cysteine modifications of pro-matrix metalloproteinase-9.
    Krishnatry AS; Kamei T; Wang H; Qu J; Fung HL
    Rapid Commun Mass Spectrom; 2011 Aug; 25(16):2291-8. PubMed ID: 21766372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3.
    Blom AB; van Lent PL; Libregts S; Holthuysen AE; van der Kraan PM; van Rooijen N; van den Berg WB
    Arthritis Rheum; 2007 Jan; 56(1):147-57. PubMed ID: 17195217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
    Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H
    Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. German cockroach frass proteases cleave pro-matrix metalloproteinase-9.
    Hughes VS; Page K
    Exp Lung Res; 2007; 33(3-4):135-50. PubMed ID: 17558676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
    Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
    Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium hydrogen exchanger and phospholipase D are required for alpha1-adrenergic receptor stimulation of metalloproteinase-9 and cellular invasion in CCL39 fibroblasts.
    Taves J; Rastedt D; Canine J; Mork D; Wallert MA; Provost JJ
    Arch Biochem Biophys; 2008 Sep; 477(1):60-6. PubMed ID: 18539131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
    Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
    Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of cartilage matrix metalloproteinases by activated protein C.
    Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
    Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes.
    Saygili E; Rana OR; Meyer C; Gemein C; Andrzejewski MG; Ludwig A; Weber C; Schotten U; Krüttgen A; Weis J; Schwinger RH; Mischke K; Rassaf T; Kelm M; Schauerte P
    Basic Res Cardiol; 2009 Jul; 104(4):435-48. PubMed ID: 19148693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
    Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
    Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).
    Fukushima K; Nakamura A; Ueda H; Yuasa K; Yoshida K; Takeda S; Ikeda S
    BMC Musculoskelet Disord; 2007 Jun; 8():54. PubMed ID: 17598883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation and modulation of 72kDa matrix metalloproteinase-2 by peroxynitrite and glutathione.
    Viappiani S; Nicolescu AC; Holt A; Sawicki G; Crawford BD; León H; van Mulligen T; Schulz R
    Biochem Pharmacol; 2009 Mar; 77(5):826-34. PubMed ID: 19046943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
    Oggionni T; Morbini P; Inghilleri S; Palladini G; Tozzi R; Vitulo P; Fenoglio C; Perlini S; Pozzi E
    Eur J Histochem; 2006; 50(4):317-25. PubMed ID: 17213041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW; Leung PC; Wong AS
    Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.